New drug combo tested to fight liver scarring from hepatitis b
NCT ID NCT07183293
Summary
This study is testing whether adding a weekly injection (peginterferon) to standard daily antiviral pills works better than the pills alone for people with stable liver scarring caused by hepatitis B. It will enroll 30 adults with compensated cirrhosis to see if the combination improves liver health and reduces complications. The main goal is to measure changes in liver tissue and stiffness over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HBV-RELATED LIVER CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Xiamen Hospital of Traditional Chinese Medicine
Xiamen, China
Contact
-
Zhongshan Hospital Affiliated to Xiamen University
Xiamen, China
Contact
Conditions
Explore the condition pages connected to this study.